Skyscape Web Viewer : The Washington Manual of Medical Therapeutics : Main Index

View All
Hepatitis B virus (HBV) AASLD treatment guidelines clinical and epidemiologic features diagnosis markers outcome and prognosis prevention principles treatment
Hepatitis C virus clinical and epidemiologic features clinical presentation diagnosis diagnostic testing outcome and prognosis prevention principles treatment
Hybrid closed loop (HCL) systems
Hydralazine Commonly Used Antihypertensive Agents by Functional Class Drugs Commonly Used for Treatment of Heart Failure Hypertension
Hydrochlorothiazide Commonly Used Antihypertensive Agents by Functional Class Drugs Commonly Used for Treatment of Heart Failure
Hydrocortisone
Hydroflumethiazide
Hydrofluoroalkane (HFA)
Hydrops fetalis
Hydroxocobalamin
Hydroxychloroquine for Q fever for systemic lupus erythematosus (SLE) rheumatoid arthritis (RA) Synthetic Dmards
Hydroxy iminodiacetic acid (HIDA) scan
Hydroxyurea for thrombocytosis sickle cell disease
Hyperaldosteronism
Hypercalcemia
Hypercapnic respiratory failure Airway Management and Endotracheal Intubation Respiratory Failure
Hypercholesterolemia
Hypercoagulable states
Hypercontractile disorder
Hypereosinophilic syndrome (HES)
Hyperglycemia critical care setting hospitalized patients Hyponatremia non-critical care hospital settings
Hyper-IgE syndrome
Hyper-IgM syndrome
Hyperkalemia Acute Kidney Injury Hyperkalemia
Hyperleukocytosis with leukostasis
Hyperlipidemia Dyslipidemia Management of Chronic Kidney Disease
Hypermagnesemia
Hypernatremia
Hyperosmolality
Hyperosmolar hyperglycemic state (HHS) complications Diabetes Mellitus in Hospitalized Patients diagnosis epidemiology Hyperosmolar Hyperglycemic State monitoring/follow-up pathophysiology treatment